Table 1.

Diagnostic criteria of metabolic syndrome

CategoryWHO, 1998 (15)IDF, 2005 (1)Original NCEP, 2001 (16,22)Modified NCEP (23)
Insulin resistanceKnown diabetes/ IFG/IGT or insulin resistance plus ≥2 criteria from the categories below
≥3 of the criteria from the categories below≥3 criteria from the categories below
ObesityBMI≥30 kg/m2 or waist-to-hip ratio >0.9 for men and >0.85 for womenWaist circumference ≥94 cm for men and ≥80 cm for women (a prerequisite) plus ≥2 of the criteria from the categories belowWaist circumference >102 cm for men and >88 cm for womenBMI>30 kg/m2 for white persons; >25 kg/m2 for Asian persons
DyslipidemiaTG≥151 mg/dl or HDL-C<34.8 mg/dl for men or <38.7 mg/dl for womenTG ≥151 mg/dlTG ≥151 mg/dlTG ≥151 mg/dl
Low HDL-C<38.7 mg/dl in men or <50.3 mg/dl in womenLow HDL-C<38.7 mg/dl in men or <50.3 mg/dl in womenLow HDL-C<38.7 mg/dl in men or <50.3 mg/dl in women
HypertensionReceiving treatment or BP≥140/90 mmHgReceiving treatment or BP≥130/85 mmHgReceiving treatment or BP≥130/85 mmHgReceiving treatment or BP≥130/85 mmHg
MicroalbuminuriaUrinary AER≥20 μg/min or ACR≥20 mg/g
DysglycemiaFPG≥101 mg/dlFPG≥101 mg/dlFPG≥101 mg/dl or receiving treatment for diabetesa
  • WHO, World Health Organization; IDF, International Diabetes Federation; NCEP, National Cholesterol Education Program; IFG, impaired fasting glucose; IGT, impaired glucose tolerance; BMI, body mass index; TG, triglyceride; HDL-C, high-density lipoprotein cholesterol; AER, albumin excretion rate; ACR, albumin-to-creatinine ratio; FPG, fasting plasma glucose.

  • a Insulin or any oral hypoglycemic agent.